ROQUEFORT THERAPEUTICS PLC Logo

ROQUEFORT THERAPEUTICS PLC

ISIN

GB00BMDQ2T15

Ticker

None

Sector

Sub-Industry

Country

United Kingdom

Year Founded

About ROQUEFORT THERAPEUTICS PLC

Headquarters

Eccleston Yards, 25 Eccleston Place
SW1W 9NF, London
United Kingdom

Financial statements

Download as Excel
Line item in (gbp) 01.01.2021 01.01.2022 01.01.2023
Current Trade Receivables N/A 15,123.00 26,430.00
Cash and cash equivalents 16,002.00 8,198.00 35,567.00
Reserve Of Sharebased Payments N/A -713,857.00 -643,122.00
Merger Reserve N/A N/A 3,700,000.00
Current Accrued Expenses And Other Current Liabilities N/A 429,255.00 480,213.00
Line item in (gbp) 01.01.2021/
01.01.2022
17.08.2021/
01.01.2022
01.01.2022/
01.01.2023
Profit (loss) -1,033,713.00 -917,433.00 -179,569.00
Line item in (gbp) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -917,433.00 -179,569.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 3,082.00 176,357.00
Cash and cash equivalents 16,002.00 8,198.00 35,567.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 English 🇬🇧 Published: 20.06.2023

Capital Markets Information

ISIN

GB00BMDQ2T15

LEI

254900P4SISIWOR9RH34

Listed Stock Exchange

London Stock Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.